Acute vascular disruption by 5,6-dimethylxanthenone-4-acetic Acid in an orthotopic model of human head and neck cancer.
about
Quantitative ex-vivo micro-computed tomographic imaging of blood vessels and necrotic regions within tumors.Monitoring antivascular therapy in head and neck cancer xenografts using contrast-enhanced MR and US imagingDMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization18F-fluromisonidazole PET imaging as a biomarker for the response to 5,6-dimethylxanthenone-4-acetic acid in colorectal xenograft tumors.The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents.Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancerNanoparticle preconditioning for enhanced thermal therapies in cancerBevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenograftsImage-guided Interstitial Photodynamic Therapy for Squamous Cell Carcinomas: Preclinical investigationSerial monitoring of human systemic and xenograft models of leukemia using a novel vascular disrupting agent.Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments.Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility.Manganese-enhanced MRI of salivary glands and head and neck tumors in living subjects.Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control.DMXAA (Vadimezan, ASA404) is a multi-kinase inhibitor targeting VEGFR2 in particular.Visualizing the effects of metformin on tumor growth, vascularity, and metabolism in head and neck cancer.
P2860
Q27330382-7A8A923E-6F95-497D-8DF7-FB700022738CQ30452632-9E0F5331-5245-4C56-93B3-9E695B09BE4BQ33773787-778B251D-89FC-472B-AE42-5B116E0AE528Q33820595-B1E135FE-C08F-4B17-ADEB-5CA205509068Q34122191-9EB23EEB-8991-445F-B720-5A42AB816C34Q34538659-4A76D8AC-69BE-44C5-B2A4-0474BAE6F5EFQ34987068-CCC03E6E-7E17-4094-B083-5A029EC2DC0CQ35028461-E21E261B-4A59-4465-85B8-EF733CA13341Q35137120-8B704594-FFEE-4DCA-8300-22EA06847042Q36225973-376DC081-7A9C-4385-B8AF-94918054308EQ38168371-47468ADB-36D9-49DB-A280-7ABF11D60438Q38757723-D02B5C8C-7B55-489C-8E39-3C11F8ECC865Q41733512-8874AF14-112C-465A-832B-6899C3DBE33CQ46189367-00FD2C9A-E4D7-409C-B16B-0ACED373B434Q52619102-72150AD3-C389-433E-8969-A7F4D92A7C33Q52639033-54217FD9-93AF-43AF-ABBE-5DB99282F23A
P2860
Acute vascular disruption by 5,6-dimethylxanthenone-4-acetic Acid in an orthotopic model of human head and neck cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Acute vascular disruption by 5 ...... of human head and neck cancer.
@en
Acute vascular disruption by 5 ...... of human head and neck cancer.
@nl
type
label
Acute vascular disruption by 5 ...... of human head and neck cancer.
@en
Acute vascular disruption by 5 ...... of human head and neck cancer.
@nl
prefLabel
Acute vascular disruption by 5 ...... of human head and neck cancer.
@en
Acute vascular disruption by 5 ...... of human head and neck cancer.
@nl
P2860
P356
P1476
Acute vascular disruption by 5 ...... of human head and neck cancer.
@en
P2093
Karoly Toth
Mukund Seshadri
P2860
P304
P356
10.1593/TLO.09103
P577
2009-08-01T00:00:00Z